Document 0172 DOCN M9650172 TI Over-expression of hepatocyte growth factor in human Kaposi's sarcoma. DT 9605 AU Maier JA; Mariotti M; Albini A; Comi P; Prat M; Comogilio PM; Soria MR; Department of Biological and Technological Research-Dibit, San; Raffaele Institute, Milan, Italy. SO Int J Cancer. 1996 Jan 17;65(2):168-72. Unique Identifier : AIDSLINE MED/96152765 AB Kaposi's sarcoma is a highly vascularized multifocal tumor which frequently appears as a complication of HIV infection. It has been suggested that a disorder in the cytokine network may contribute to the development of the disease. We examined the expression of several cytokines in human sporadic Kaposi's-sarcoma specimens, as well as in spindle cells cultured from human lesions, and consistently found high levels of expression of hepatocyte growth factor (HGF). In addition, human lesion-derived spindle cells synthesize and secrete biologically active hepatocyte growth factor and express the hepatocyte-growth-factor receptor (c-MET). Moreover, elevated levels of transforming growth factor beta 1 (TGF beta 1) mRNA were found in lesions of human sporadic Kaposi's sarcoma and in lesion-derived spindle cells which also over-express urokinase. Since HGF, TGF beta 1 and urokinase are all involved in capillary-vessel organization, dysregulation of these interacting agents may play a role in the initiation and/or progression of Kaposi's sarcoma, stimulating the growth of spindle cells and recruiting endothelial cells into the lesion. DE Base Sequence Fibroblast Growth Factor, Basic/BIOSYNTHESIS Hepatocyte Growth Factor/*BIOSYNTHESIS Human Male Molecular Sequence Data Polymerase Chain Reaction Receptor Protein-Tyrosine Kinase/BIOSYNTHESIS RNA, Messenger/*BIOSYNTHESIS Sarcoma, Kaposi's/*METABOLISM/PATHOLOGY Support, Non-U.S. Gov't Transforming Growth Factor beta/*BIOSYNTHESIS Tumor Cells, Cultured JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).